Single-cell profiling identifies pre-existing CD19-negative subclones in a B-ALL patient with CD19-negative relapse after CAR-T therapy | Nature Communications
Flow Cytometry of Hematological Malignancies: 9781119611257: Medicine & Health Science Books @ Amazon.com
Frontiers | Mechanisms of Relapse After CD19 CAR T-Cell Therapy for Acute Lymphoblastic Leukemia and Its Prevention and Treatment Strategies
Generation and characterization of CD19-iCre mice as a tool for efficient and specific conditional gene targeting in B cells | Scientific Reports
PD-1 and TIGIT downregulation distinctly affect the effector and early memory phenotypes of CD19-targeting CAR T cells: Molecular Therapy
CD19/BAFF-R dual-targeted CAR T cells for the treatment of mixed antigen-negative variants of acute lymphoblastic leukemia | Leukemia
Frontiers | Failure of ALL recognition by CAR T cells: a review of CD 19-negative relapses after anti-CD 19 CAR-T treatment in B-ALL
Cancers | Free Full-Text | CD19 Chimeric Antigen Receptor-Exosome Targets CD19 Positive B-lineage Acute Lymphocytic Leukemia and Induces Cytotoxicity
A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL: Molecular Therapy
CD19 Monoclonal Antibody (HIB19) (14-0199-82)
Cancers | Free Full-Text | Combination of High-Resolution Structures for the B Cell Receptor and Co-Receptors Provides an Understanding of Their Interactions with Therapeutic Antibodies
Frontiers | Cytokines induced memory-like NK cells engineered to express CD19 CAR exhibit enhanced responses against B cell malignancies
Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors | Nature Reviews Clinical Oncology
Frontiers | Getting CD19 Into Shape: Expression of Natively Folded “Difficult-to- Express” CD19 for Staining and Stimulation of CAR-T Cells
Resources for CD 19 | Biomarker for normal and neplastic B cell | OriGene
Cells | Free Full-Text | Sensitivity and Specificity of CD19.CAR-T Cell Detection by Flow Cytometry and PCR
CAR.CD19 T-cells generated from Bcp-ALL patients' derived PBMCs... | Download Scientific Diagram
Overview of CD19-targeted chimeric antigen receptor (CAR)-T-cell... | Download Scientific Diagram
CD19-The Most Popular Target with CAR T-Cell Therapy-CUSABIO
CD19: a promising B cell target for rheumatoid arthritis | Nature Reviews Rheumatology
Screening for CD19-specific chimaeric antigen receptors with enhanced signalling via a barcoded library of intracellular domains | Nature Biomedical Engineering
CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial | Nature Medicine
Human CD19 B Cell Flow Cytometry Panel FMC-P-003: R&D Systems
CD19 - an overview | ScienceDirect Topics
of CD19 and CD20 expression during B cell development. CD19 expression... | Download Scientific Diagram
Selective B cell depletion upon intravenous infusion of replication-incompetent anti-CD19 CAR lentivirus: Molecular Therapy Methods & Clinical Development
Anti-human CD3/CD19 bispecific antibody | InvivoGen
Trispecific CD19-CD20-CD22–targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models | Science Translational Medicine
